While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
KXMA Bismarck on MSN10h
ND Legis: Ozempic and Wegovy
Ozempic and Wegovy ...
There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Possibly the best of the celebrity ads was Dunkin’ Donuts ‘DunKings 2’ with Ben and Casey Affleck and a really terrific bit from Succession alum Jeremy Strong, leaning heavily into his reputation as a ...
Hims and Hers has been slammed for its Super Bowl commercial that admonished Americans for being obese and shamed the healthcare industry - then promoted its own weight loss drugs.  The 60-second ...
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
An academic study of the merger hopes to give insight into how attorneys general can strengthen certificate-of-need laws and the importance of having more power over sales. Other industry news focuses ...
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...